West Nile virus infection among the homeless, Houston, Texas

Emerging Infectious Diseases

Volumn 13, Issue 10, 2007, Pages 1500-1503

  Meyer, Tamra E ^a   Bull, Lara M ^a   Holmes, Kelly Cain ^a   Pascua, Rhia F ^a   Da Rosa, Amelia Travassos ^b   Gutierrez, Christian R ^a   Corbin, Tracie ^a   Woodward, Jennifer L ^a   Taylor, Jeffrey P ^c   Tesh, Robert B ^b   Murray, Kristy O ^a,d  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANNABIS ADDICTION; CONTROLLED STUDY; FEMALE; HOMELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOSQUITO; PUBLIC HEALTH SERVICE; RISK FACTOR; SEROPREVALENCE; UNITED STATES; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

EID: 35549006795     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1310.070442     Document Type: Article

References (10)

1. Lillibridge KM, Parsons R, Randle Y, Travassos da Rosa AP, Guzman H, Siirin M, et al. The 2002 introduction of West Nile virus into Harris County, Texas, an area historically endemic for St. Louis encephalitis. Am J Trop Med Hyg. 2004;70:676-81.
2. Murray K, Baraniuk S, Resnick M, Arafat R, Kilborn C, Cain K, et al. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect. 2006;134:1325-32.
3. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: John Wiley; 2000.
4. Healthcare for the Homeless - Houston, Inc. Health, Hope and Dignity Program narrative. [cited 2007 Mar 8]. Available from http://www.homeless- healthcare.org/hhh/overview
5. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001;358:261-4.
6. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, et al. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis. 2006;12:395-402.
7. Schweitzer BK, Kramer WL, Sambol AR, Meza JL, Hinrichs SH, Iwen PC. Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic. Clin Vaccine Immunol. 2006;13:314-8.
8. Murphy TD, Grandpre J, Novick SL, Seys SA, Harris RW, Musgrave K. West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors. Vector Borne Zoonotic Dis. 2005;5:246-51.
9. Mandalakas AM, Kippes C, Sedransk J, Kile JR, Garg A, McLeod J, et al. West Nile virus epidemic, northeast Ohio, 2002. Emerg Infect Dis. 2005;11:1774-7.
10. McCarthy TA, Hadler JL, Julian K, Walsh SJ, Biggerstaff BJ, Hinten SR, et al. West Nile virus serosurvey and assessment of personal prevention efforts in an area with intense epizootic activity: Connecticut, 2000. Ann N Y Acad Sci. 2001;951:307-16.